ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial

por Bauman, J E, Austin, M C, Schmidt, R, Kurland, B F, Vaezi, A, Hayes, D N, Mendez, E, Parvathaneni, U, Chai, X, Sampath, S, Martins, R G
Publicado 2013